Vulvar lichen sclerosus: Effect of maintenance treatment with a moisturizer on the course of the disease

Menopause

Volumn 15, Issue 1, 2008, Pages 74-77

  Simonart, Thierry ^a   Lahaye, Marc ^b   Simonart, Jean Marie ^c  

^a ERASME HOSPITAL   (Belgium)

^b Centre Médical des Champs Elysées   (Belgium)

^c NONE

Author keywords

Dyspareunia; Genital atrophy; Moisturizer; Vulvar lichen sclerosus

Indexed keywords

BETAMETHASONE VALERATE; EMOLLIENT AGENT;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MAINTENANCE THERAPY; POSTMENOPAUSE; PROSPECTIVE STUDY; RELAPSE; SCAR FORMATION; SQUAMOUS CELL CARCINOMA; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VULVA;

ADMINISTRATION, TOPICAL; BETAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; OINTMENTS; PATIENT SATISFACTION; POSTMENOPAUSE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VULVAR LICHEN SCLEROSUS; WOMEN'S HEALTH;

EID: 38049006482     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3180616689     Document Type: Article

References (14)

1. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999;353:1777-1783.
2. Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002;147:640-649.
3. Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynecol Obstet 1994;46:53-56.
4. Dalziel KL. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med 1995;40:351-354.
5. Carli P, Cattaneo A, De Magnis A, Biggeri A, Taddei G, Giannotti B. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev 1995;4:491-495.
6. Simonart T, Noel JC, De Dobbeleer G, Simonart JM. Carcinoma of the glans penis arising 20 years after lichen sclerosus. Dermatology 1998;196:337-338.
7. Diakomanolis ES, Haidopoulos D, Syndos M, et al. Vulvar lichen sclerosus in postmenopausal women: a comparative study for treating advanced disease with clobetasol propionate 0.05%. Eur J Gynaecol Oncol 2002;23:519-522.
8. Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol 2004;140:709-712.
9. Assmann T, Becker-Wegerich P, Grewe M, Megahed M, Ruzicka T. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 2003;48:935-937.
10. Dalziel KL, Wojnarowska F. Long-term control of vulval lichen sclerosus after treatment with a potent topical steroid cream. Reprod Med 1993;38:25-27.
11. Dalziel KL, Millard PR, Wojnarowska F. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol 1991;124:461-464.
12. Loden M, Andersson AC, Lindberg M. Improvement in skin barrier function in women with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999;140:264-267.
13. Held E, Lund H, Agner T. Effect of different moisturizers on SLS-irritated human skin. Contact Dermatitis 2001;44:229-234.
14. Kikuchi K, Kobayashi H, Hirao T, Ito A, Takahashi H, Tagami H. Improvement of mild inflammatory changes of the facial skin induced by winter environment with daily applications of a moisturizing cream. A half-side test of biophysical skin parameters, cytokine expression pattern and the formation of cornified envelope. Dermatology 2003;207:269-275.